Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium

Neurobiology of Aging

Volumn 38, Issue , 2016, Pages 141-150

  Hohman, Timothy J ^a   Bush, William S ^b   Jiang, Lan ^a   Brown Gentry, Kristin D ^a   Torstenson, Eric S ^a   Dudek, Scott M ^a   Mukherjee, Shubhabrata ^c   Naj, Adam ^d   Kunkle, Brian W ^e   Ritchie, Marylyn D ^f   Martin, Eden R ^e   Schellenberg, Gerard D ^g   Mayeux, Richard ^h   Farrer, Lindsay A ^i,j   Pericak Vance, Margaret A ^e   Haines, Jonathan L ^b   Thornton Wells, Tricia A ^k  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BOSTON UNIVERSITY   (United States)

^k VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Alzheimer disease; Biofilter; Epistasis; Gene gene interactions

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; RYANODINE RECEPTOR 3; SIRTUIN 1; ABCB1 PROTEIN, HUMAN; ADRA1A PROTEIN, HUMAN; ALPHA 1 ADRENERGIC RECEPTOR; CACNA1C PROTEIN, HUMAN; CADHERIN; CALCIUM CHANNEL L TYPE; CDH23 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR; PE-BINDING PROTEIN 4, HUMAN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PSAP PROTEIN, HUMAN; RYANODINE RECEPTOR; SIRT1 PROTEIN, HUMAN; SPHINGOLIPID ACTIVATOR PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ENDOPHENOTYPE; EPIGENETICS; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MULTIFACTORIAL INHERITANCE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; DISEASE COURSE; EPISTASIS; FEMALE; GENETIC ASSOCIATION STUDY; GENETICS; INFORMATION PROCESSING; MALE; RISK;

ALZHEIMER DISEASE; CADHERINS; CALCIUM CHANNELS, L-TYPE; DATASETS AS TOPIC; DISEASE PROGRESSION; EPISTASIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MODELS, GENETIC; P-GLYCOPROTEINS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, N-METHYL-D-ASPARTATE; RISK; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SAPOSINS; SIRTUIN 1;

EID: 84962285532     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.10.031     Document Type: Article

References (42)

1. Andreoli V., De Marco E.V., Trecroci F., Cittadella R., Di Palma G., Gambardella A. Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease. J. Neural Transm. 2014, 121:533-542.
2. Arosio B., Trabattoni D., Galimberti L., Bucciarelli P., Fasano F., Calabresi C., Cazzullo C.L., Vergani C., Annoni G., Clerici M. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 2004, 25:1009-1015.
3. Baki L., Marambaud P., Efthimiopoulos S., Georgakopoulos A., Wen P., Cui W., Shioi J., Koo E., Ozawa M., Friedrich V.L., Robakis N.K. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2381-2386.
4. Belbin O., Carrasquillo M.M., Crump M., Culley O.J., Hunter T.A., Ma L., Bisceglio G., Zou F., Allen M., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum. Genet 2011, 129:273-282.
5. Bush W.S., Dudek S.M., Ritchie M.D. Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac. Symp. Biocomput. 2009, 368-379.
6. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J. Alzheimers. Dis. 2011, 24:751-758.
7. Caselli R.J., Reiman E.M., Locke D.E., Hutton M.L., Hentz J.G., Hoffman-Snyder C., WoodruffB.K., Alexander G.E., Osborne D. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch. Neurol. 2007, 64:1306-1311.
8. Combarros O., Warden D.R., Hammond N., Cortina-Borja M., Belbin O., Lehmann M.G., Wilcock G.K., Brown K., Kehoe P.G., Barber R., Coto E., Alvarez V., Deloukas P., Gwilliam R., Heun R., Kölsch H., Mateo I., Oulhaj A., Arias-Vásquez A., Schuur M., Aulchenko Y.S., Ikram M.A., Breteler M.M., van Duijn C.M., Morgan K., Smith A.D., Lehmann D.J. The dopamine beta-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med. Genet. 2010, 11:162.
9. Donmez G., Wang D., Cohen D.E., Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010, 142:320-332.
10. Elali A., Rivest S. The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease. Front. Physiol. 2013, 4:45.
11. Gatz M., Reynolds C.A., Fratiglioni L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
12. Herold C., Steffens M., Brockschmidt F.F., Baur M.P., Becker T. INTERSNP: genome-wide interaction analysis guided by a priori information. Bioinformatics 2009, 25:3275-3281.
13. Heun R., Kolsch H., Ibrahim-Verbaas C.A., Combarros O., Aulchenko Y.S., Breteler M., Schuur M., van Duijn C.M., Hammond N., Belbin O., Cortina-Borja M., Wilcock G.K., Brown K., Barber R., Kehoe P.G., Coto E., Alvarez V., Lehmann M.G., Deloukas P., Mateo I., Morgan K., Warden D.R., Smith A.D., Lehmann D.J. Interactions between PPAR-alpha and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. Int. J. Mol. Epidemiol. Genet. 2012, 3:39-47.
14. Hohman T.J., Koran M.I., Thornton-Wells T.A. Epistatic effects among Alzheimer's candidate genes. PLoS One 2013, 8:e80839.
15. Katsouri L., Vizcaychipi M.P., McArthur S., Harrison I., Suarez-Calvet M., Lleo A., Lloyd D.G., Ma D., Sastre M. Prazosin, an alpha(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 2013, 34:1105-1115.
16. Kauwe J.S., Bertelsen S., Mayo K., Cruchaga C., Abraham R., Hollingworth P., Harold D., Owen M.J., Williams J., Lovestone S., Morris J.C., Goate A.M. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:955-959. Alzheimer's Disease Neuroimaging Initiative.
17. Kohen R., Shofer J.B., Korvatska O., Petrie E.C., Wang L.Y., Schellenberg G.D., Peskind E.R., Wilkinson C.W. ABCB1 genotype and CSF beta-amyloid in Alzheimer disease. J. Geriatr. Psychiatry Neurol. 2011, 24:63-66.
18. Kolsch H., Lehmann D.J., Ibrahim-Verbaas C.A., Combarros O., van Duijn C.M., Hammond N., Belbin O., Cortina-Borja M., Lehmann M.G., Aulchenko Y.S., Schuur M., Breteler M., Wilcock G.K., Brown K., Kehoe P.G., Barber R., Coto E., Alvarez V., Deloukas P., Mateo I., Maier W., Morgan K., Warden D.R., Smith A.D., Heun R. Interaction of insulin and PPAR-alpha genes in Alzheimer's disease: the Epistasis Project. J. Neural Transm. 2012, 119:473-479.
19. Koran M.I., Hohman T.J., Meda S.A., Thornton-Wells T. Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size. J. Alzheimer's Dis. 2014, 38:145-154.
20. Koran M.I., Hohman T.J., Thornton-Wells T.A. Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography. Hum. Genet. 2014, 133:85-93.
21. Kowalski T.J., Pawelczyk M., Rajkowska E., Dudarewicz A., Sliwinska-Kowalska M. Genetic variants of CDH23 associated with noise-induced hearing loss. Otol. Neurotol. 2014, 35:358-365.
22. Kuhnke D., Jedlitschky G., Grube M., Krohn M., Jucker M., Mosyagin I., Cascorbi I., Walker L.C., Kroemer H.K., Warzok R.W., Vogelgesang S. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides-implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 2007, 17:347-353.
23. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., DeStafano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., Russo G., Thorton-Wells T.A., Jones N., Smith A.V., Chouraki V., Thomas C., Ikram M.A., Zelenika D., Vardarajan B.N., Kamatani Y., Lin C.F., Gerrish A., Schmidt H., Kunkle B., Dunstan M.L., Ruiz A., Bihoreau M.T., Choi S.H., Reitz C., Pasquier F., Cruchaga C., Craig D., Amin N., Berr C., Lopez O.L., De Jager P.L., Deramecourt V., Johnston J.A., Evans D., Lovestone S., Letenneur L., Morón F.J., Rubinsztein D.C., Eiriksdottir G., Sleegers K., Goate A.M., Fiévet N., Huentelman M.W., Gill M., Brown K., Kamboh M.I., Keller L., Barberger-Gateau P., McGuiness B., Larson E.B., Green R., Myers A.J., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., St George-Hyslop P., Clarimon J., Lleo A., Bayer A., Tsuang D.W., Yu L., Tsolaki M., Bossù P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Sanchez-Garcia F., Fox N.C., Hardy J., Deniz Naranjo M.C., Bosco P., Clarke R., Brayne C., Galimberti D., Mancuso M., Matthews F., Moebus S., Mecocci P., Del Zompo M., Maier W., Hampel H., Pilotto A., Bullido M., Panza F., Caffarra P., Nacmias B., Gilbert J.R., Mayhaus M., Lannefelt L., Hakonarson H., Pichler S., Carrasquillo M.M., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin S.G., Coto E., Hamilton-Nelson K.L., Gu W., Razquin C., Pastor P., Mateo I., Owen M.J., Faber K.M., Jonsson P.V., Combarros O., O'Donovan M.C., Cantwell L.B., Soininen H., Blacker D., Mead S., Mosley T.H., Bennett D.A., Harris T.B., Fratiglioni L., Holmes C., de Bruijn R.F., Passmore P., Montine T.J., Bettens K., Rotter J.I., Brice A., Morgan K., Foroud T.M., Kukull W.A., Hannequin D., Powell J.F., Nalls M.A., Ritchie K., Lunetta K.L., Kauwe J.S., Boerwinkle E., Riemenschneider M., Boada M., Hiltuenen M., Martin E.R., Schmidt R., Rujescu D., Wang L.S., Dartigues J.F., Mayeux R., Tzourio C., Hofman A., Nöthen M.M., GraffC., Psaty B.M., Jones L., Haines J.L., Holmans P.A., Lathrop M., Pericak-Vance M.A., Launer L.J., Farrer L.A., van Duijn C.M., Van Broeckhoven C., Moskvina V., Seshadri S., Williams J., Schellenberg G.D., Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45:1452-1458. European Alzheimer's Disease Initiative (EADI), Genetic, Environmental Risk in Alzheimer's DiseaseGenetic, Environmental Risk in Alzheimer's Disease, Alzheimer's Disease Genetic ConsortiumAlzheimer's Disease Genetic Consortium, Cohorts for Heart, Aging Research in Genomic EpidemiologyCohorts for Heart, Aging Research in Genomic Epidemiology.
24. Liang W.S., Chen K., Lee W., Sidhar K., Corneveaux J.J., Allen A.N., Myers A., Villa S., Meechoovet B., Pruzin J., Bandy D., Fleisher A.S., Langbaum J.B., Huentelman M.J., Jensen K., Dunckley T., Caselli R.J., Kaib S., Reiman E.M. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEepsilon4 carriers. Neuroimage 2011, 54:1896-1902.
25. Lord J., Cruchaga C. The epigenetic landscape of Alzheimer's disease. Nat. Neurosci. 2014, 17:1138-1140.
26. Mansoori N., Tripathi M., Luthra K., Alam R., Lakshmy R., Sharma S., Arulselvi S., Parveen S., Mukhopadhyay A.K. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction. Neurobiol. Aging 2012, 33:1003-1008.
27. Mateo I., Infante J., Rodriguez E., Berciano J., Combarros O., Llorca J. Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk. J. Neurol. Neurosurg. Psychiatry 2006, 77:278-279.
28. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
29. Miyagawa M., Nishio S.Y., Usami S. Prevalence and clinical features of hearing loss patients with CDH23 mutations: a large cohort study. PLoS One 2012, 7:e40366.
30. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
31. Nakanishi H., Ohtsubo M., Iwasaki S., Hotta Y., Takizawa Y., Hosono K., Mizuta K., Mineta H., Minoshima S. Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1. J. Hum. Genet. 2010, 55:796-800.
32. Pendergrass S.A., Frase A., Wallace J., Wolfe D., Katiyar N., Moore C., Ritchie M.D. Genomic analyses with Biofilter 2.0: knowledge driven filtering, annotation, and model development. BioData. Min. 2013, 6:25.
33. Pruim R.J., Welch R.P., Sanna S., Teslovich T.M., Chines P.S., Gliedt T.P., Boehnke M., Abecasis G.R., Willer C.J. LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics. 2010, 26:2336-2337.
34. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.W., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
35. Qin W., Yang T., Ho L., Zhao Z., Wang J., Chen L., Zhao W., Thiyagarajan M., MacGrogan D., Rodgers J.T., Puigserver P., Sadoshima J., Deng H., Pedrini S., Gandy S., Sauve A.A., Pasinetti G.M. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 2006, 281:21745-21754.
36. Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lince D., Huentelman M.J., Craig D.W., Coon K.D., Liang W.S., Herbert R.H., Beach T., Rohrer K.C., Zhao A.S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C.B., Ravid R., Rogers J., Hutton M.L., Melquist S., Petersen R.C., Alexander G.E., Caselli R.J., Kukull W., Papassotiropoulos A., Stephan D.A. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007, 54:713-720.
37. Ridge P.G., Mukherjee S., Crane P.K., Kauwe J.S.K. Alzheimer's disease: analyzing the missing heritability. PLoS One 2013, 8:e79771.
38. Riekkinen M., Stefanski R., Kuitunen J., Riekkinen P. Effects of combined block of α 1-adrenoceptors and NMDA receptors on spatial and passive avoidance behavior in rats. Eur. J. Pharmacol. 1996, 300:9-16.
39. Robson K.J., Lehmann D.J., Wimhurst V.L., Livesey K.J., Combrinck M., Merryweather-Clarke A.T., Warden D.R., Smith A.D. Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. J. Med. Genet. 2004, 41:261-265.
40. So H.-C., Gui A.H., Cherny S.S., Sham P.C. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 2011, 35:310-317.
41. Wang Z., Chen W. Emerging roles of SIRT1 in Cancer drug Resistance. Genes Cancer 2013, 4:82-90.
42. Webster J.A., Gibbs J.R., Clarke J., Ray M., Zhang W., Holmans P., Rohrer K., Zhao A., Marlowe L., Kaleem M., McCorquodale III D.S., Cuello C., Leung D., Bryden L., Nath P., Zismann V.L., Joshipura K., Huentelman M.J., Hu-Lince D., Coon K.D., Craig D.W., Pearson J.V., Heward C.B., Reiman E.M., Stephan D., Hardy J., Myers A.J. Genetic control of human brain transcript expression in Alzheimer disease. Am. J. Hum. Genet. 2009, 84:445-458. NACC-Neuropathology Group.